cerrar
Tagged with

“Watch Out! Unsophisticated AI in Healthcare Can Perpetuate…
As the healthcare industry continues to hype about AI's potential to be transformative, it is important to remember that even software can harbour a…

Emmanuelle Quilès – CEO, Janssen France
Emmanuelle Quilès, CEO of Janssen France, speaks about how she joined the American multinational with the ambition to bring digitalization and…

Xu Ting – Founder, Chairman and CEO, Alphamab Oncology,…
Dr Xu Ting, founder, chairman and CEO of Alphamab Oncology, shares his expert opinion on the recent regulatory and healthcare reforms in China, the…

Guillaume Freneuil – Vice President Intercontinental…
Ipsen’s Guillaume Freneuil gives his take on the importance of the Algerian market to the global group.   If we are investing right now in…

H. Samuel Muk – President & CEO, Korea Drug…
The Korea Drug Development Fund (KDDF) is a government-funded organization created to accelerate innovation activities in the Korean life sciences…

The IFPMA’s New Code of Practice: PharmaBoardroom Readers…
Across the month of January, we at PharmaBoardroom surveyed our executive readership on attitudes towards the International Federation of…

NEW Special Pharma Report on Algeria
Click here to download the Healthcare & Life Sciences Review Algeria 2019 report. Algeria, Africa’s largest country by area, stands…

‘Reimagined’ Novartis Grows 5% in 2018
Basel-headquartered pharma giant Novartis announced its financial results for 2018 this week, showcasing full year net sales growth of five percent…

Martin Dubuc – General Manager, Biogen France
Martin Dubuc, general manager of Biogen France, discusses the company’s strong leadership in neurosciences, its commitment to pioneering the…

Nam Han Cho – President, International Diabetes Federation,…
Dr Nam Han Cho, president of the International Diabetes Federation (IDF) and professor of Preventive Medicine at the Ajou University School of…

Turkish Pharma: Imports & Exports Snapshot
Imports and exports in Turkish pharma between 2010 and 2017. Pharmaceutical exports grew to a total of USD 898 million in 2017.…

The UK to Incentivise Big Pharma Firms to Develop New…
In recent years, apocalyptic conversations around superbugs caused by antimicrobial resistance (AMR) have been on the up, but just in case we were…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here